Loading...
- Melanoma 16
- Humans 15
- Cancer 8
- Children 7
- Female 7
- Hematopoietic stem cell transplantation 6
- Male 6
- Prognosis 6
- Acute lymphoblastic leukemia 5
- Animals 5
- Melanocytes 5
- Relapse 5
- Adolescent 4
- Cell Line 4
- Child 4
- Childhood cancer 4
- DNA-Binding Proteins 4
- Gene Expression Regulation 4
- Mice 4
- Pigmentation 4
- Transcription Factors 4
- Tumor 4
- CRISPR-Cas9 3
- Chemotherapy 3
- Childhood leukaemia 3
- Childhood leukemia 3
- DNA 3
- Epidemiology 3
- Genetic 3
- Genetics 3
- Human 3
- Inflammasomes 3
- Inflammation 3
- Leukemia 3
- Methotrexate 3
- Oncology 3
- Pediatrics 3
- Personalized medicine 3
- Prophylaxis 3
- Signal Transduction 3
- Staphylococcus aureus 3
- Stem cell transplantation 3
- Survival 3
- TYRP1 3
- Transcription 3
- Ultraviolet Rays 3
- Upstream Stimulatory Factors 3
- Acute myeloid leukemia 2
- AhR 2
- Alcohol 2
- Antineoplastic Agents 2
- Antineoplastic Combined Chemotherapy Protocols 2
- Antisense oligonucleotide 2
- Aryl hydrocarbon receptor 2
- Bacterial clearance 2
- Biological 2
- Breslow 2
- CRISPR-Cas9 gene editing 2
- CYP450 2
- Caspase-1 2
- Cell Cycle 2
- Cell cycle 2
- Chimerism 2
- Chromatin Immunoprecipitation 2
- Chromosomes 2
- Circular RNAs 2
- Colorectal cancer 2
- Controlled study 2
- Dog 2
- Epigenetics 2
- Etiology 2
- Expression 2
- France 2
- Gene mutation 2
- Genes 2
- Graft versus host disease 2
- Hematopoietic Stem Cell Transplantation 2
- Immunity 2
- Inflammasome 2
- Interleukin-8 2
- Iron 2
- Late effects 2
- Major clinical study 2
- Management 2
- Melanins 2
- MiRNA sponge 2
- Models 2
- Multiplex 2
- Mutation 2
- Neoplasm 2
- Oncogenes 2
- P53 2
- Panel 2
- Pediatric oncology 2
- Pharmacogenetics 2
- Phosphorylation 2
- Precursor Cell Lymphoblastic Leukemia-Lymphoma 2
- Preschool 2
- Primary immunodeficiency 2
- Promoter Regions 2
- Prophylaxie 2
- Quality 2
- RNA 2
- Radiotherapy 2
- Regulation network 2
- Residual 2
- Resistance 2
- SARS-CoV-2 2
- Sensitivity and Specificity 2
- Sequence Deletion 2
- Skin 2
- Skin Neoplasms 2
- Sponge mechanism 2
- Spontaneous model 2
- Targeted therapy 2
- Transcriptomic data 2
- Transfection 2
- UV 2
- 11q23 1
- AIDS 1
- AML1 1
- ASO 1
- ASO-therapy 1
- ASSAY 1
- Accompagnement social 1
- Aceruloplasminemia 1
- Actin cytoskeleton 1
- Actinic keratosis 1
- Acute leukemia 1
- Acute lymphoblastic 1
- Adhesion 1
- Adjuvants 1
- Adolescent cancer 1
- Adolescents 1
- Adolescents and young adults 1
- Adult 1
- Agents 1
- AhR nuclear translocator 1
- AhR transcription factor 1
- Akt 1
- Allele 1
- Allogeneic stem cell transplant 1
- Allogreffe de cellules hématopoïétiques 1
- Allosteric inhibitor 1
- Amino Acid Motifs 1
- Anciens patients 1
- Anemia 1
- Aneurysm 1
- Anti-EGFR mAb 1
- Antisense oligonucleotides 1
- Aplastic anemia 1
- Appariement non canonique 1
- Article 1
- Artificial intelligence 1
- Aryl hydrocarbon Receptor 1
- Atransferrinemia 1
- Aurora-A 1
- B cell 1
- B-Cell 1
- B-cells 1
- BRAF inhibitor 1
- BRAF testing 1
- BRAFi resistance 1
- Bacterial regulatory RNAs 1
- Base Sequence 1
- Benzoapyrene 1
- Bevacizumab 1
- Binding Sites 1
- Biogenesis 1
- Biology 1
- Biomarker 1
- Biomedicine general 1
- Blast Crisis 1
- Blotting 1
- Bone Neoplasms 1
- Bone marrow 1
- Brain 1
- Brain Diseases 1
- Breast feeding 1
- Brittany 1
- Busulfan 1
- C-KIT 1
- CD19 1
- CD9 1
- CDK4 1
- CDNA microarrays 1
- COMMUNITY-ACQUIRED PNEUMONIA 1
- COVID 19 1
- CRISPR-SAM 1
- CXCR2 1
- CYP1A1 1
- CaMK 1
- Cadherins 1
- Caesarean section 1
- Canavanine 1
- Cancer Research 1
- Cancer dans l’enfance 1
- Cancer mortality 1
- Cancer prognosis 1
- Cancers 1
- Case-control study 1
- Case–control study 1
- Cathéter central 1
- Cell Cycle Proteins 1
- Cell Movement 1
- Cell Proliferation 1
- Cell Transformation 1
- Cell differentiation 1
- Cell motility 1
- Cell plasticity 1
- Cell proliferation 1
- Cell therapy 1
- Cells 1
- Cellular microenvironment 1
- Central catheter 1
- Central nervous system 1
- Centrosome 1
- Childhood 1
- Childhood acute leukemia 1
- Childhood cancers 1
- Chimera 1
- Chimeric antigen receptor 1
- Chromosomal rearrangement 1
- Chromosomal rearrangements 1
- Chromosome Breakpoints 1
- Chromosome Mapping 1
- Chronic hepatitis 1
- Chronic intestinal pseudoobstruction 1
- Cisplatin 1
- Clofarabine 1
- Coffee 1
- Cohort 1
- Cohort Studies 1
- Cohort analysis 1
- Cohort study 1
- Colon cancer 1
- Combined Modality Therapy 1
- Comparative Genomic Hybridization 1
- Complementary 1
- Computational Biology 1
- Conditioning regimen 1
- Congenital sideroblastic anemia 1
- Considérations éthiques 1
- Copolymers 1
- Cord blood transplantation 1
- Cord blood unit 1
- Core Binding Factor Alpha 2 Subunit 1
- Coronary Disease 1
- Cultured 1
- Cumulative sun exposure 1
- Cutaneous squamous cell carcinoma 1
- Cycle cellulaire 1
- Cyclin-Dependent Kinase Inhibitor p21 1
- Cyclophosphamide 1
- Cyclosporine 1
- Cytogenetics 1
- Cytology 1
- Cytopenia 1
- DMT1 1
- DNA Damage 1
- DNA Polymerase III 1
- DNA damage 1
- DNA damages 1
- DNA extraction 1
- DNA mismatch repair 1
- DNA-Directed DNA Polymerase 1
- DSD 1
- Database 1
- Day-care 1
- Deep learning 1
- Dermatoscopie 1
- Desmoplastic melanoma 1
- Diagnosis 1
- Diagnostic 1
- Digital pathology 1
- Disease free survival 1
- Disease-Free Survival 1
- Dog model 1
- Dogmodel 1
- Dommages à ADN 1
- Driver loop 1
- Drug Eruptions 1
- Drug Resistance 1
- Drug dose reduction 1
- Drug metabolism 1
- Drug therapy 1
- Drug transporter 1
- Défaillance d’organes 1
- Dépistage 1
- E-Box Elements 1
- E-cadherin 1
- ELANE-related neutropenia 1
- ETO2 1
- ETV6/RUNX1 1
- Early 1
- Eccrine Glands 1
- Editing 1
- Emergency hospital admission 1
- Endonucleases 1
- Endothelium 1
- Enfant 1
- Engraftment 1
- Enterocytes 1
- Epidemiology and prevention 1
- Epigenetic 1
- Epistasis 1
- Epithelial Cells 1
- Epithelial-Mesenchymal Transition 1
- Ethical considerations 1
- Event free survival 1
- Exome sequencing 1
- Extramedullary 1
- Ezrin 1
- Ezrin-radixin-moesin protein 1
- FIR 1
- Facteur de transcription 1
- Fas 1
- Fas-mediated apoptosis nonstructural 5a protein caspase-activated dnase core protein transgenic mice signaling pathway viral-proteins cytochrome-c kinase pkr hiv-1 nef 1
- Ferritin 1
- Ferroportin 1
- First professional insertion 1
- Flavonoids 1
- Fludarabine 1
- Follow up 1
- Frameshift mutation 1
- Fungal 1
- Fungal Proteins 1
- Fusion gene 1
- Fusion protein 1
- Fusions 1
- Gastric cancer 1
- Gene 1
- Gene Expression 1
- Gene Expression Profiling 1
- Gene Knockdown Techniques 1
- Gene deletion 1
- Gene expression 1
- Gene frequency 1
- Genetic Testing 1
- Genetic disoders 1
- Genetic instability 1
- Genome 1
- Genome editing 1
- Genotype 1
- Glucose 1
- Graft rejection 1
- Graft versus host reaction 1
- Haematopoietic stem cells 1
- Hearing Loss 1
- Helicobacter pylori infection 1
- Helix-Loop-Helix Motifs 1
- Hematology 1
- Heme-oxygenase 1 1
- Hemin overload 1
- Hemochromatosis 1
- Hemoglobin blood level 1
- HepaRG cell line 1
- HepaRG cells 1
- Hepatitis E virus 1
- Hepatocellular carcinoma 1
- Hepatocyte 1
- Hepatocytes 1
- Histiocytic sarcoma 1
- Histology 1
- Historical comparisons 1
- Human cell 1
- Human hepatocytes 1
- Hurler-Scheie disease 1
- Hybrid-capture based genomic profiling 1
- Hypermutated 1
- Hypoxia 1
- ID1 1
- INFLUENZA 1
- IRIDA 1
- IRIDA iron refractory iron deficiency anemia 1
- Identifiable information 1
- Ifosfamide 1
- Ikaros Transcription Factor 1
- Immune checkpoint inhibitors 1
- Immunocompromised children 1
- Immunologic 1
- Immunotherapy 1
- Immunotoxicity 1
- In vitro toxicity 1
- Incidence 1
- Incidental finding 1
- Indoles 1
- Infant 1
- Infection 1
- Infection fongique invasive 1
- Infections 1
- Informed consent 1
- Inhibitor 1
- Inorganic arsenic 1
- Intensive care unit 1
- Interactome des miARN 1
- Intergenic 1
- Interleukin-2 1
- Internal medicine 1
- Invasive fungal infection 1
- Inégalités 1
- Iron blood level 1
- Iron chelation 1
- Iron deficiency 1
- Iron metabolism 1
- Iron metabolism disorders 1
- Iron overload 1
- Iron-oxide nanoparticles 1
- JIROVECII 1
- KH domain 1
- KRAS 1
- KRAS and BRAF mutations 1
- Knockout 1
- Langerhans cell histiocytosis 1
- Letter 1
- Leucine Zippers 1
- Leucémie de l’enfant 1
- Leukemia Myeloid Acute 1
- Leukemia remission 1
- Leukopenia 1
- Lipid rafts 1
- Liver level 1
- Local 1
- Location of the primary melanoma 1
- Luciferases 1
- Lung epithelial cells 1
- Lymphoblastic leukemia 1
- Lymphoblastic lymphoma 1
- Lymphoblastic malignancies 1
- Lymphocyte Activation 1
- Lymphocyte Count 1
- Lymphocytes 1
- MANAGEMENT 1
- MDM2 1
- MITF 1
- MLL 1
- MRI 1
- MYH11 1
- Macrophage 1
- Magnetic Resonance Imaging 1
- Malignancy 1
- Marker 1
- Mastitis infection 1
- Matched related donor 1
- Matched sibling donor 1
- Matched unrelated donor 1
- Matriptase 1
- Medical society 1
- Medical tool 1
- Medicine 1
- Melanomas 1
- Membrane Glycoproteins 1
- Membrane fluidity 1
- Messenger 1
- Metaplasia 1
- Metastasis 1
- Methylation 1
- Mélanome uvéal 1
- MiR-16 1
- MiR-31-3p 1
- MiRNA 1
- MiRNA interactome 1
- MiRNA targetome 1
- MiRNAs 1
- MicroRNA 1
- MicroRNAs 1
- Microarray analysis 1
- Microarray analysis of gene expression 1
- Microcirculation 1
- Microphthalmia 1
- Microphthalmia-Associated Transcription Factor 1
- Microsatellite 1
- Microsatellite instability 1
- Microtubule 1
- Migration 1
- Minimal residual disease 1
- Mismatch repair deficiency 1
- Missense mutation 1
- Mitf 1
- Mitosis 1
- Mixed method 1
- Mixtures 1
- Moesin 1
- Molecular 1
- Molecular targeted therapy 1
- Molecular tumor board 1
- Monosomy 7 1
- Mucopolysaccharidosis type I 1
- Mucosal melanoma 1
- Multiplex Polymerase Chain Reaction 1
- Multivariate analysis 1
- Musculoskeletal abnormalities 1
- Muskel-Skelett-Anomalien 1
- Mutagens 1
- Mutations 1
- Mycophenolate mofetil 1
- Myeloablative conditioning 1
- Myelodysplasia 1
- Médecin Généraliste 1
- Mélanocyte 1
- Mélanome 1
- Méthode mixte 1
- NHR2 1
- NIH 3T3 Cells 1
- Nanobubbles 1
- Nanoparticles 1
- Neoplasien 1
- Neoplasm Invasiveness 1
- Neoplasm Metastasis 1
- Neoplasm Recurrence 1
- Neoplasms 1
- Neoplastic 1
- Next generation sequencing 1
- Niche 1
- Non canonical base pairing 1
- Non-Hodgkin's lymphomas 1
- Non-UV pathways 1
- Non-adherent cells 1
- Nonsense mutation 1
- Nuclear factor NF- κ B 1
- Nuclear magnetic resonance 1
- Nucleofection™ 1
- Nucleofection™ Human hepatocytes 1
- Nucleophomin 1
- Nucleotide Excision Repair 1
- Oligonucleotide Array Sequence Analysis 1
- Opportunistic infections 1
- Organ failure 1
- Organization 1
- Osteoblast 1
- Osteonectin 1
- Osteosarcoma 1
- Overall survival 1
- Oxidoreductases 1
- P21 1
- P38 Mitogen-Activated Protein Kinases 1
- P65 1
- PD-1 1
- PNEUMOCYSTIS PNEUMONIA 1
- PTPN11 1
- Pair 7 1
- Parental smoking 1
- Peau 1
- Pediatric cancer 1
- Pediatric patient 1
- Pembrolizumab 1
- Perinatal factors 1
- Personalized survivorship care plan 1
- Pesticides 1
- Pets 1
- Pharmacokinetics 1
- Phase I 1
- Philadelphia chromosome-positive acute lymphoblastic leukemia 1
- Phosphatidylinositol 3-Kinases 1
- Pituitary Hormone 1
- Pla 1
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1
- Pregnancy 1
- Premature ovarian insufficiency 1
- Première insertion professionnelle 1
- Pro-Opiomelanocortin 1
- Procedures 1
- Professionals 1
- Professionnels 1
- Prospective Studies 1
- Protein Binding 1
- Protein Structure 1
- Proto-Oncogene Proteins c-akt 1
- Proximity ligation assay 1
- Psychosocial studies 1
- Public Health 1
- Pédiatrie 1
- Quality of care 1
- Quality of life 1
- Quality of work life 1
- RANTES 1
- REAL-TIME PCR 1
- RNA Interference 1
- RNA interference 1
- RNA modifications 1
- RNA-seq 1
- ROCK 1
- RUNX1 1
- RUNX1 gene 1
- RUNX1 protein human 1
- Rad52 DNA Repair and Recombination Protein 1
- Radiation therapy 1
- Reactive oxygen species 1
- Real time polymerase chain reaction 1
- Receptors 1
- Registry 1
- RelB 1
- Remission Induction 1
- Reponse immune 1
- Reporter 1
- Reproducibility of Results 1
- Resistant disease 1
- Retinoblastoma Protein 1
- Retrospective Studies 1
- Retrospective study 1
- RhoA-GTP 1
- Risk Factors 1
- Risk assessment 1
- Risk factor 1
- Ruxolitinib 1
- Réanimation 1
- Régulation transcriptionnelle 1
- Réparation par excision de nucléotide 1
- Résistance 1
- SEPT 1
- SERUM PROCALCITONIN 1
- SMAD3 1
- SNP 1
- SPECIMENS 1
- Saccharomyces cerevisiae 1
- Saccharomyces cerevisiae Proteins 1
- Sanctuary 1
- Scoliosis 1
- Second primary 1
- Secondary 1
- Secondary leukemia 1
- Sentinel Lymph Node Biopsy 1
- Septin 1
- Severe congenital neutropenia 1
- Sexual development 1
- Shwachman-Diamond syndrome 1
- Siderophore 1
- Signaling pathway 1
- Single-Strand Specific DNA and RNA Endonucleases 1
- Skin Pigmentation 1
- Skoliose 1
- Smoking 1
- Societies Medical 1
- Solid organ transplantation 1
- Solvents 1
- Somatic mutations 1
- Souris-knock-in 1
- Spectrophotometry 1
- Spätfolgen 1
- Stabilization 1
- Staphyloccocus Aureus 1
- Staphylococcus aureus S aureus 1
- Stem Cell Transplantation 1
- Strahlentherapie 1
- Sulfonamides 1
- Sunlight 1
- Suppresseur de tumeur 1
- Supramolecular structures 1
- Survivorship 1
- T cell 1
- TBX3 1
- TRACT INFECTIONS 1
- Tacrolimus 1
- Tanning response 1
- Targeted therapy resistance 1
- Targetome des miARN 1
- Telomeres 1
- Testis 1
- Tetraspanin 1
- Thalassemia 1
- Therapeutic approaches 1
- Therapeutic drug monitoring 1
- Therapeutic option 1
- Thymocyte antibody 1
- Thérapies ciblées 1
- Time Factors 1
- Toll-like receptors 1
- Total body irradiation 1
- Trained immunity 1
- Traitement 1
- Trans-acting RNA 1
- Transcription factor 1
- Transcription factor RUNX1 1
- Transcription factors 1
- Transcriptional Activation 1
- Transcriptional Regulation 1
- Transfusion dependent thalassemia 1
- Transgenes 1
- Transplantation Conditioning 1
- Transplantation conditioning 1
- Treatment 1
- Treatment Outcome 1
- Treatment outcome 1
- Tumor Markers 1
- Tumor Suppressor 1
- Tumor Suppressor Protein p53 1
- Tumor Suppressor Proteins 1
- Tumor mutational burden TMB 1
- Tumor suppressor 1
- Tumour vasculature heterogeneity 1
- Tyrosine kinase inhibitors 1
- USF-1 1
- UV signature 1
- Ulceration 1
- Usf1 1
- Uterus 1
- Uv 1
- Uveal Melanoma 1
- V600E 1
- Venous thromboembolism 1
- Vesicles 1
- Voies de signalisation 1
- Water 1
- Western 1
- Wilms tumor 1
- Wilms' tumor 1
- Young adults 1
- Young survivors 1
- Zweite primäre 1
- Épissage alternatif 1
- ÉsThrombose veineuse 1